PAULA NICHOLS: Open Payments
NPI 1225449945 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 44 payments from 19 companies in 2025. Trend: 2023 $1,795 · 2024 $1,612 · 2025 $1,589
Food & beverage: $1,589
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $175 |
| Abbott Laboratories | 8 | $161 |
| Novartis Pharmaceuticals Corporation | 8 | $156 |
| ABIOMED | 1 | $126 |
| Corcept Therapeutics | 1 | $123 |
| SCPHARMACEUTICALS INC. | 1 | $123 |
| Alnylam Pharmaceuticals Inc. | 1 | $122 |
| Actelion Pharmaceuticals US, Inc. | 1 | $121 |
| Kestra Medical Technology Services, Inc. | 3 | $112 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $96 |
Products named: LEQVIO, Ozempic, Korlym, FUROSCIX, AMVUTTRA, UPTRAVI, Assure WCD, JOURNAVX.
Industry payments across TX — which companies pay providers there.
